B
Bio-FD&C Co Ltd
KOSDAQ:251120
Bio-FD&C Co Ltd
KOSDAQ:251120
Price:
15 200
KRW
-3.55%
Market Closed
Market Cap:
₩132.2B
Relative Value
The Relative Value of one Bio-FD&C Co Ltd stock under the Base Case scenario is hidden KRW. Compared to the current market price of 15 200 KRW, Bio-FD&C Co Ltd is hidden .
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
Bio-FD&C Co Ltd Relative Value
HIDDEN
Multiples Across Competitors
Competitors Multiples
Bio-FD&C Co Ltd Competitors
Bio-FD&C Co Ltd Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| KR |
B
|
Bio-FD&C Co Ltd
KOSDAQ:251120
|
129.6B KRW | 6.9 | 18.3 | 10.7 | 12.7 | |
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD | 33 643 258.8 | -159 901.4 | -194 171.3 | -191 955.6 | |
| US |
|
Abbvie Inc
NYSE:ABBV
|
397.7B USD | 6.7 | 171.2 | 16.6 | 23.5 | |
| US |
|
Amgen Inc
NASDAQ:AMGN
|
182.7B USD | 5.1 | 26.3 | 18.8 | 18.8 | |
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
179.8B USD | 6.2 | 22.2 | 15 | 15 | |
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
117.6B USD | 10.1 | 32.2 | 23.6 | 24.7 | |
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR | 2 094 | -534.3 | -581.8 | -566.3 | |
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
79.5B USD | 5.6 | 17.8 | 15.1 | 17.2 | |
| AU |
|
CSL Ltd
ASX:CSL
|
86.7B AUD | 3.9 | 20.1 | 13.4 | 16.8 | |
| NL |
|
argenx SE
XBRU:ARGX
|
43.5B EUR | 14.5 | 34.2 | 58.4 | 60.1 | |
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR | 20.2 | -61.8 | -66.7 | -60.2 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
